scispace - formally typeset
Open AccessJournal ArticleDOI

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.

Reads0
Chats0
TLDR
In this article, the authors describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.
About
This article is published in The Lancet.The article was published on 2021-01-16 and is currently open access. It has received 2933 citations till now. The article focuses on the topics: Pulmonary diffusion & Severity of illness.

read more

Citations
More filters
Journal ArticleDOI

Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge

TL;DR: In this article , the authors used proteomic and metabolomic approaches to analyze plasma samples obtained from 30 healthy subjects and 54 COVID-19 survivors 6 months after discharge from the hospital, including 30 non-severe and 24 severe patients.
Journal ArticleDOI

Is There a Connection Between Gut Microbiome Dysbiosis Occurring in COVID-19 Patients and Post-COVID-19 Symptoms?

TL;DR: According to the WHO, currently 215 countries/areas/territories report a total of more than 176 million confirmed COVID-19 cases and 3.8 million deaths (June 18, 2021).
Journal ArticleDOI

Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: Data from 3,078 health care workers

TL;DR: In this paper, the authors investigated whether the risk of severe and moderate systemic symptoms (MSS) after vaccination is higher in HCWs with a history of previous COVID-19 and identified factors associated to MSS by logistic regression.
References
More filters
Journal ArticleDOI

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

TL;DR: A 5-level version of the EQ-5D has been developed by the EuroQol Group and further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Journal ArticleDOI

Dexamethasone in Hospitalized Patients with Covid-19

TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
Related Papers (5)
Trending Questions (1)
What is the implications of reshoring after covid?

The given text does not provide any information about the implications of reshoring after COVID-19.